Drug Profile
Research programme: cachexia therapy - Gastrotech
Alternative Names: GTP-3XXLatest Information Update: 09 Dec 2008
Price :
$50
*
At a glance
- Originator Gastrotech Pharma
- Class
- Mechanism of Action Somatotropin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cachexia
Most Recent Events
- 09 Dec 2008 No development reported - Preclinical for Cachexia in Denmark (unspecified route)
- 01 Dec 2005 Preclinical trials in Cachexia in Denmark (unspecified route)